Rev. 2010] - Kenya Law Reports



(Repealed by Act 21 of 1994)

CHAPTER 245

DANGEROUS DRUGS ACT

Commencement Date: 1933-02-01

An Act of Parliament to regulate the importation, exportation, manufacture, sale and use of opium and other dangerous drugs

PART I - PRELIMINARY

Short title. 

1. This Act may be cited as the Dangerous Drugs Act.

Interpretation. 

2. In this Act, except where the context otherwise requires -

"coca leaves" means the leaves of any plant of the genus of the Erythroxylaceae from which cocaine can be extracted either directly or by chemical transformation;

"the Geneva Convention (No. 1)" means the convention signed at Geneva on the 19th February, 1925, for the purpose of completing and strengthening the provisions of the Hague Convention;

"the Geneva Convention (No. 2)" means the convention signed at Geneva on the 13th July, 1931, for limiting the manufacture and regulating the distribution of narcotic drugs;

"the Hague Convention" means the International Convention signed at The Hague on the 23rd January, 1912;

"Indian hemp" means the dried flowering or fruiting tops of the pistillate plant known as cannabis sativa from which the resin has not been extracted, by whatever name such tops are called;

"medicinal opium" means raw opium which has undergone the processes necessary to adapt it for medicinal use in accordance with the requirements of the British Pharmacopoeia, whether it is in the form of powder or is granulated or is in any other form, and whether it is or is not mixed with neutral materials;

"prepared opium" means opium prepared for smoking, and includes dross and any other residues remaining after opium has been smoked, and also includes any opium, for whatever purpose prepared, which is capable of being smoked;

"raw opium" includes powdered or granulated opium, but does not include medicinal opium.

PART II - RAW OPIUM AND COCA LEAVES

Restriction of import and export of raw opium and coca leaves

L.N.187/1956,

L.N.172/1960. 

3. (1) No person shall import or export raw opium or coca leaves except under licence and into or from prescribed ports or places.

(2) If at any time the importation of raw opium or coca leaves into a foreign country is prohibited or restricted by the laws of that country, there shall, while that prohibition or restriction; is in force, be attached to every licence which is issued under this Act authorizing the export of raw opium or coca leaves from Kenya such conditions as may appear to the licensing officer to be necessary for preventing or restricting, as the case may be, the exportation of raw opium or coca leaves from Kenya to that country during such time as the importation of raw opium or coca leaves into that country is so prohibited or restricted, and any such licences issued before the prohibition or restriction came into force shall, if the Minister by order so directs, be deemed to be subject to the same conditions.

Power to regulate production of and dealing in raw opium and coca leaves. L.N.188/1956,

L.N.173/1960. 

4. The Minister may make rules for controlling or restricting the production, possession, sale and distribution of raw opium or coca leaves, and in particular, but without prejudice to the generality of the foregoing power, for prohibiting the production, possession, sale or distribution of raw opium or coca leaves except by persons licensed or otherwise authorized in that behalf, and for controlling or restricting the possession of or dealing in raw opium or coca leaves while in transit through Kenya, whether by land, by air or by water.

Prohibition of trade, etc., in new drugs, and power to apply Part V to certain drugs. L.N.187/1956,

L.N.172/1960. 

5.(1) No person shall in Kenya trade in or manufacture for the purpose of trade any products obtained from any of the phenanthrene alkaloids of opium or from the ecgonine alkaloids of the coca leaf, not being a product which was on the 13th July, 1931, being used for medical or scientific purposes:

Provided that, if the Minister is at any time satisfied as respects any such product that it is of medical or scientific value, he may by order direct that this subsection shall cease to apply to that product.

(2) If it is made to appear to the Minister that a decision with respect to any such product as is mentioned in subsection (1) has in pursuance of Article 11 of the Geneva Convention (No 2) been communicated to the parties to that Convention, the Minister, by order, may, as the case requires, either declare that the provisions of Part V of this Act shall apply to that product in the same manner as they apply to the drugs mentioned in subsection (1) of section 14 or apply Part V to that product with such modifications as may be specified in the order.

(3) The Minister may by order apply Part V, with such modifications as may be specified in the order, to methylmorphine (commonly known as codeine), ethylmorphine (commonly known as dionin) and their respective salts.

Prohibition of cultivation of opium or coca plant. 

6. No person shall cultivate the opium poppy (papaver somniferum) or the

coca plant (Erythroxylum coca).

PART III - PREPARED OPIUM

Prohibition of export and import of prepared opium. 

7. No. person shall import or export prepared opium.

Penalty for manufacturing. selling, using, etc., prepared opium. 

8. A person who -

(a) manufactures, sells or otherwise deals in prepared opium; or

(b) has in his possession any prepared opium; or

(c) being the occupier of premises, permits those premises to be used for the purpose of the preparation of opium for smoking or the sale or smoking of prepared opium; or

(d) is concerned in the management of premises used for any such purpose; or

(e) has in his possession any pipes or other utensils for use in connexion with the smoking of opium, or any utensils used in connexion with the preparation of opium for smoking; or

(f) smokes or otherwise uses prepared opium, or frequents a place used for the purpose of opium smoking,

shall be guilty of an offence.

PART IV - INDIAN HEMP

Prohibition of import and export of Indian hemp and resin from plant cannabis sativa. 

9. No person shall import or export Indian hemp, or any resin obtained from the plant cannabis sativa, or any products of which that resin forms the base (excluding such products which are used solely for medicinal purposes):

Provided that where Indian hemp, resin or products are imported solely for the purpose of transit (including deviation) through Kenya, or are exported immediately after having been imported for that purpose, the goods shall not be deemed to have been imported or exported within the meaning of this section.

Offences respecting plant cannabis sativa and resin therefrom. 

10. A person who -

(a) produces, sells or otherwise deals in Indian hemp, or resin obtained from the plant cannabis saliva, or any products of which that resin forms the base; or

(b) has in his possession any Indian hemp, or any resin from the plant cannabis sativa, or any products of which that resin forms the base, except when the Indian hemp, resin or products are in transit through Kenya, whether by land, by air or by water; or

(c) cultivates the plant cannabis sativa: or

(d) sells or otherwise deals in the whole or any portion of the plant cannabis sativa (excluding its medicinal preparations); or

(e) has in his possession the whole or any portion of the plant cannabis sativa (excluding its medicinal preparations),

shall be guilty of an offence.

Rules respecting Indian hemp and resin from plant cannabis sativa in transit through Kenya.

L.N.188/1956,

L.N.173/1960. 

11. The Minister may make rules for controlling or restricting the possession of or dealing in Indian hemp, or resin obtained from the plantcannabissativa, or products of which that resin forms the base, while the Indian hemp, resin or products is or are in transit through Kenya, whether by land, by air or by water.

PART V - COCAINE, MORPHINE, ETC.

Restriction on import and export of cocaine, etc. 

12. No person shall import or export a drug to which this Part applies, except under licence, and into or from prescribed ports or places.

Rules for control of cocaine, etc.

L.N.188/1956,

L.N.173/1960,

L.N.3/1962.

Cap. 244. 

13.(1) For the purpose of preventing the improper use of the drugs to which this Part applies, the Minister may make rules for controlling the manufacture, sale, possession and distribution of those drugs, and in particular, but without prejudice to the generality of the foregoing, for -

(a) prohibiting the manufacture of a drug to which this Part applies except on premises licensed for the purpose and subject to conditions specified in the licence; and

(b) prohibiting the manufacture, sale or distribution of any such drug except by persons licensed or otherwise authorized under rules made under this Act and subject to any conditions specified in the licence or authority; and

(c) regulating the issue by medical practitioners of prescriptions containing any such drug and the dispensing of any such prescriptions; and

(d) requiring persons engaged in the manufacture, sale or distribution of any such drug to keep such books and furnish such information either in writing or otherwise as may be prescribed; and

(e) controlling or restricting the possession of or dealing in any such drug while in transit through Kenya, whether by land, by air or by water.

(2) Rules under this section shall provide for authorizing a person who lawfully keeps open shop for the retailing of poisons in accordance with the Pharmacy and Poisons Act;

(a) to manufacture at the shop in the ordinary course of his retail business any preparation, admixture or extract of any drug to which this Part applies; or

(b) to carry on at the shop the business of retailing, dispensing or compounding any such drug,

subject to the power of the Minister to withdraw the authorization in the case of a person who has been convicted of an offence under this Act or rules made thereunder and who cannot, in the opinion of the Minister, properly be allowed to carry on the business of manufacturing or selling or distributing, as the case may be, any such drug.

(3) Nothing in rules made under this section shall be taken to authorize the sale, or the keeping of an open shop for the retailing, dispensing or compounding, of poisons by a person who is not qualified in that behalf under, or otherwise than in accordance with, the Pharmacy and Poisons Act, or to be in derogation of the provisions of that Act for prohibiting, restricting or regulating the sale of poisons.

Drugs to which Part applies.

L.N.188/1956,

L.N.173/1960. 

14.(1) The drugs to which this Part applies are -

(a) medicinal opium;

(b) an extract or tincture of Indian hemp;

(c) morphine and its salts, and diacetylmorphine (commonly known as diamorphine or heroin) and other esters of morphine and their respective salts;

(d) Cocaine(including synthetic coccaine) and ecgonine and their respective salts, and the esters of ecgonine and their respective salts;

(e) a solution or dilution of morphine or cocaine or their salts in an inert substance whether liquid or solid, containing a proportion of morphine or cocaine, and a preparation, admixture, extract or other substance (not being such a solution or dilution as aforesaid) containing not less than one-fifth per centum of morphine or one-tenth per centum of cocaine or of ecgonine;

(f) a preparation, admixture, extract or other substance containing a proportion of diacetylmorphine;

(g) dihydrohydroxycodeinone, dihydrocodeinone, dihydromorphinone, acetyldihydrocodeinone, dihydromorphine, their esters and the salts of any of these substances and of their esters, morphine-N-oxide (commonly known as genomorphine), the morphine- N-oxide derivatives, and any other pentavalent nitrogen morphine derivatives;

(h) thebaine and its salts, and (with the exception of methylmorphine, commonly known as codeine, and ethylmorphine, commonly known as dionin, and their respective salts) benzylmorphine and the other ethers of morphine and their respective salts;

(i) a preparation, admixture, extract or other substance containing a proportion of any of the substances mentioned in, paragraph (g) or (h).

(2) For the purposes of subsection (1) "ecgonine" means laevo-ecgonine, and includes derivatives of ecgonine from which it may be recovered industrially, and the percentage in the case of morphine shall be calculated as in respect of anhydrous morphine.

(3) For the purposes of this section percentages in the case of liquid preparations shall, unless other provision in that behalf is made by rules made under this Act, be calculated on the basis that a preparation containing one per centum of any substance means a preparation in which one gramme of the substance, if a solid, or one millilitre of the substance, if a liquid, is contained in every hundred millilitres of the preparation, and so in proportion, for any greater or less percentage.

(4) If it appears to the Minister that any new derivative of morphine or cocaine or of any salts of morphine or cocaine or any other alkaloid of opium or any other drug of whatever kind is or is likely if improperly used to be productive, or is capable of being converted into a substance which is or is likely if improperly used to be productive, of ill-effects substantially of the same character or nature as or analogous to those produced by morphine or cocaine, the Minister may by order provide that this Part shall apply to that new derivative or alkaloid or other drug in the same manner as it applies to the drugs mentioned in subsection (1).

(5) If the Minister thinks fit to declare that a finding with respect to a preparation containing any of the drugs to which this Part applies has in pursuance of Article 8 of the Geneva Convention (No. 1) been communicated to the parties to that Convention, the provisions of this Part shall, as from the date specified in the declaration, cease to apply to the preparations specified therein.

PART VI - GENERAL

Licences.

L.N.188/1956

L.N.173/1960 

15. Licences, permits or authorities for the purposes of this Act may be issued or granted by such person on such terms and subject to such conditions (including in the case of a licence the payment of a fee) as the Minister may prescribe.

Exporter or agent liable for contravention regarding export. 

16. If any goods prohibited to be exported by virtue of this Act or rules made thereunder are exported in contravention thereof, or brought to a quay or other place to be shipped for the purpose of being so exported or of being waterborne to be so exported, the exporter or his agent shall be guilty of an offence.

Powers of inspection and seizure. 

17.(1) A police officer or other person authorized in seizure, that behalf by a general or special order of the Commissioner of Police, of the Director of Medical Services or of a Provincial Commissioner may, for the purposes of the execution of this Act, enter the premises of a person carrying on the business of; a producer, manufacturer, seller or distributor of drugs to which this Act applies, and demand the production of and inspect books or documents relating to dealings in any such drugs, and to inspect stocks of any such drugs.

(2) If a magistrate is satisfied by information on oath that there is reasonable ground for suspecting that-

(a) drugs to which this Act applies are, in contravention of the provisions of this Act or rules made thereunder, in the possession or under the control of any person in any premises; or

(b) a document directly or indirectly relating to or connected with a transaction or dealing which was, or an intended transaction or dealing which would if carried out be, an offence under this Act or rules made thereunder or, in the case of a transaction or dealing carried out or intended to be carried out in a place outside Kenya, an offence under any corresponding law in force in that place is in the possession or under the control of any person in any premises,

he may grant a search warrant authorizing a police officer named in the warrant, at any time or times within one month from the date of the warrant, to enter, if need be by force, the premises named in the warrant, and to search the premises and any persons found therein, and if there is reasonable ground for suspecting that an offence under this Act or rules made thereunder has been committed in relation to any such drugs which may be found in the premises or in possession of any such persons, or that any document which may be so found is a document as aforesaid, to seize and detain those drugs or that document, as the case may be.

(3) If it appears to a police officer that delay occasioned by obtaining a search warrant will defeat the objects of this section, he may exercise the powers conferred by subsection (2) as if he were in possession of a search warrant, but he shall as soon as possible report what he has done to a magistrate.

(3) A person who wilfully delays or obstructs a person in the exercise of his powers under this section, or fails to produce or conceals or attempts to conceal any such books, stocks, drugs or documents, shall be guilty of an offence.

Offences and penalties

25 of 1968, Sch.,

4 of 1974, Sch.,

19 of 1982,Sch. 

18. (1) A person who -

(a) acts in contravention of, or fails to comply with, any provision of this Act or of rules made under section 4 or section 13;or

(b) acts in contravention of, or fails to comply with, the conditions of a licence or permit issued or authority granted under or in pursuance of this Act or rules made thereunder; or

(c) for the purpose of obtaining, whether for himself or for another person, the issue, grant or renewal of any such licence, permit or authority, makes a declaration or statement which is false in any particular, or knowingly utters, produces or makes use of any such declaration or statement or any document containing it; or

(d) in Kenya aids, abets, counsels or procures the commission outside Kenya of an offence punishable under a corresponding law in force in that place, or does an act preparatory to, or in furtherance of an act which if committed in Kenya would constitute an offence under this Act or rules made thereunder,

shall be guilty of an offence.

(2) A person who is guilty of an offence under this Act or rules made thereunder shall be liable to a fine not exceeding twenty thousand shillings, or to imprisonment for a term not exceeding ten years, or to both.

(3) No person shall, on conviction for an offence of contravening or failing to comply with any rule under this Act once relating to the keeping of books or the issuing or dispensing of prescriptions containing drugs to which this Act applies, be sentenced to imprisonment without the option of a fine or to a fine exceeding one thousand shillings, if the court dealing with the case is satisfied that the offence was committed through inadvertence and was not preparatory to, or committed in the course of, or in connexion with, the commission or intended commission of another offence under this Act or rules made thereunder.

(4) If a person attempts to commit an offence under this Act or rules made thereunder, or solicits or incites another person to commit such an offence, he shall be guilty of an offence and, without prejudice to any other liability, liable to the punishment and forfeiture as if he had committed the offence attempted.

(5) Where a person convicted of an offence under this Act or under any rules made thereunder is a company, the chairman and every director and every officer concerned in the management of the company shall be guilty of the offence, unless he proves that the act constituting the offence took place without his knowledge or consent.

(6) An offence under this Act shall be triable by any subordinate court.

Definition of "corresponding law". 

19. In sections 17 and 18 "corresponding law" means a law stated in a certificate purporting to be issued by or on behalf of the government of a country outside Kenya to be a law providing for the control and regulation in that country of the manufacture, sale, use, export and import of drugs in accordance with the Hague Convention, the Geneva Convention (No.1) or the Geneva Convention (No.2) and a statement in any such certificate as to the effect of the law mentioned in the certificate, or a statement in any such certificate that any facts constitute an offence against that law shall be conclusive.

Power of arrest. 

20. A police officer or medical officer in the service of the Government may arrest without warrant a person who has committed, or attempted to commit, or is reasonably suspected by the officer of having committed or attempted to commit, an offence under this Act or rules made thereunder, if he has reasonable ground for believing that that person will abscond unless arrested, or if the name and address of that person are unknown to and cannot be ascertained by him.

Meaning of importation and exportation under licence. 

21.For the purposes of this Act an article shall be deemed to be imported under licence or exported under licence if the importer or exporter is the holder of a licence issued under this Act authorizing the importation or exportation of the article and complies with the conditions of the licence, but not otherwise.

Burden of proof. 

22. In proceedings against a person for an offence Burden of proof under this Act or rules made thereunder, it shall not be necessary to negative by evidence a licence, authority or other matter of exception or defence, and the burden of proving any such matter shall lie on the person seeking to avail himself thereof.

Rules.

L.N.188/1956.

L.N.173/1960,

L.N.690/1961. 

23. The Minister may make rules -

(a) providing for the forms of declarations, certificates or permits made or issued for the purposes of this Act and the conditions (if any) to be contained therein;

(b) prescribing the hours within which and the manner in which a declaration of a drug to which this Act applies shall be made by the master or person in charge of a ship or other conveyance;

(c) regulating the arrival and berthing of ships or aircraft carrying a drug to which this Act applies;

(d) providing for the rendering of periodical returns by a person being in possession of or producing or manufacturing a drug to which this Act applies within Kenya, and for the rendering by a person of an estimate of the amount of any such drug to be imported by him during a period to be prescribed by the rules, to such officer as the Minister shall appoint in that behalf;

(e) generally for the better carrying out of the objects and purposes of this Act.

Rewards. 

24. Where, on conviction for an offence under this Act or rules made thereunder, a fine is imposed, the court may award an amount, not exceeding four hundred shillings, of the fine recovered as a reward to a person (not being a person whose duty it is to detect or assist in the detection of such offences) who gave information leading to the conviction.

SUBSIDIARY LEGISLATION

Orders under section 5 (1) proviso

THE DANGEROUS DRUGS (RELAXATION) ORDER

1. This Order may be cited as the Dangerous Drugs (Relaxation) Order.

2. Section 5 (1) of the Act shall cease to apply to the drugs N-Allylnormorphine and Morpholinylothylmorphine.

Rules under sections 13 (1) and 23

THE DANGEROUS DRUGS RULES

ARRANGEMENT OF RULES

Cap. 129 (1948),

Sub. Leg.

G.N. 1027/1951.

L.N. 140/1959

L.N. 755/1961

L.N. 151/1968

PART 1 – PRELIMINARY

Rule

1—Citation.

2—Application.

3—Interpretation.

PART II—MANUFACTURE, SALE, DISTRIBUTION AND POSSESSION OF COCAINE, MORPHINE ETC.

4—Manufacture under licence only.

5—Restrition on supply and procuring of drugs.

6—Further restrictions on distribution except where medically prescribed.

7—Prescriptions.

8—Dispensing of prescriptions.

9—Conditions of prossession.

10—Marking of packages or bottles.

11—Registers to be kept by persons supplying.

12—Alternative to keeping register.

13—Meaning of “proper reference”.

14—Inspection of registers.

15—Seller of poisons may manufacture, etc., in certain cases.

16—Medical practitioner, etc., may possess and supply drugs in certain cases.

17—Withdrawal of authority.

18—Delivery to messengers.

19—When drugs in possession of person.

20—Power to exempt hospitals, etc.

21—Exemption of certain preparations.

22—Preservation of records.

PART III-CONTROL OF EXTERNAL TRADE

23—Interpretation of part.

24—Export of dangerous drugs.

25—Import of dangerous drugs.

26—Dangerous drugs in transit

27—Removal licence.

28—Drugs not to be tampered with.

29—Diversion of dangerous drugs.

30—Periodical returns.

31—Drugs to be imported or exported only through appointed ports.

SCHEDULES

Citation.

1. These Rules may be cited as the Dangerous Drugs Rules.

Application.

2. The dangerous drugs to which these Rules apply are those to which Part V of the Act applies, and “drug” and “dangerous drug” shall be construed accordingly.

Interpretation.

Cap. 253.

Cap. 366

3. In these Rules, except where the context otherwise requires—

“dentist” means a person for the time being registered or licensed as a dentist under the Medical Practitioners and Dentists Act;

“veterinary surgeon” means a person for the time being registered or licensed as a veterinary surgeon under the Veterinary Surgeons Act.

PART II—MANUFACTURE, SALE, DISTRIBUTION AND POSSESSION OF COCAINE, MORPHINE, ETC.

Manufacture under licence only.

4. No person shall manufacture or carry on any process in the manufacture of drugs—

(a) unless he is licensed by the Director of Medical Services or is authorized by this Part or by an authority granted by the Director of Medical Services to do so;

(b) except on premises licensed for the purpose by the Director of Medical Services;

(c) otherwise than in accordance with the terms and conditions of the licence or authority.

Restriction on supply and procuring of drugs.

5. No person shall supply or procure, drugs to or for any (including himself) and whether of in Kenya or elsewhere, or advertise drugs for sale—

(a) unless he is licensed by the Director of Medical Services or is authorized by this Part or by an authority granted by the Director of Medical Services to supply the drugs, or unless he is licensed by the Director of Medical Services to import or export the drugs, or unless he is licensed or otherwise authorized to manufacture the drugs, or (but so far only as regards procuring) unless he is licensed to procure them;

(b) otherwise than in accordance with the terms and conditions of the licence or authority.

Further restrictions on distribution except when medically prescribed.

6. (1) Except when drugs are lawfully dispensed in pursuance of a prescription given by a medical practitioner, dentist or veterinary surgeon, or are supplied by a medical practitioner or veterinary surgeon who dispenses his own medicines in accordance with the conditions specified in this Part, no person shall supply or procure, or offer to supply or procure, any of the drugs to or for a person in Kenya who is not licensed or otherwise authorized to be in possession of the drug nor to a person so licensed or authorized except in accordance with the terms and conditions of a licence or authority.

(2) The administration of a drug by or under the direct personal supervision of a medical practitioner, or dentist in dental treatment, or by or under the direct personal supervision of a veterinary surgeon in the treatment of an animal, shall not be deemed to be supplying the drug within the meaning of this Part.

Prescriptions.

7. A prescription for the supply of drugs shall comply with the Prescriptions following conditions—

(a) the prescription shall be iii writing, and shall be dated and signed by the person giving it, with his address, the name and address of the person for whose use it is given and the total amount of the drug to be supplied on the prescription;

(b) a prescription shall only be given by a medical practitioner when required for the purposes of medical treatment;

(c) a prescription shall only be given by a dentist for the purposes of dental treatment, and shall be marked “For local dental treatment only;

(d) a prescription shall only be given by a veterinary surgeon for the purposes of treatment of animals, and shall be marked “For animal treatment only”;

(e) the Director of Medical Services may lay down and issue a form (in this Part referred to as the official form) for use in giving prescriptions for drugs; and in that case a prescription shall be given on the official form; but in a case of emergency when the person giving the prescription has not the official form available, the prescription may be given without using the official form, and in that case it shall be marked with the words “Official form not available” or with similar words;

(f) a medical practitioner, dentist or veterinary surgeon shall not give a prescription for the supply of drugs otherwise than in accordance with the conditions set out in this Part;

(g) a medical practitioner, dentist or veterinary surgeon who dispense drugs shall enter particulars thereof in his day book or in the register hereinafter specified.

Dispensing of prescriptions.

8. The following conditions shaft be observed by persons dispensing prescriptions for drugs—

(a) if the official form is laid down and issued by the Director of Medical Services in pursuance of rule 7, a prescription for drugs shall only be dispensed if the prescription is on one of those forms, or, in the case of an emergency prescription given under the conditions specified in rule 7, if the person dispensing the prescription is acquainted with the signature of the medical practitioner, dentist or veterinary surgeon by who the prescription purports to be given, or is acquainted with the person for whose use the prescription is given and has no reason to suppose that the prescription is not genuine;

(b) if an official form is not laid down, a prescription for drugs shall only be dispensed if either—

(i) the person dispensing the prescription is acquainted with the signature of the person by whom it purports to have been given, and has no reason to suppose that it is not genuine; or

(ii) the person dispensing the prescription has taken reasonably sufficient steps to satisfy himself that it is genuine;

(c) if the prescription so directs, drugs may be supplied on more than one but not exceeding three occasions, as directed in the prescription, at intervals to be specified in the prescription, but drugs shall not otherwise be supplied more than once on the same prescription;

(d) the person dispensing a prescription shall mark thereon the date on which it is dispensed, and shall retain it and keep it on the premises where it is dispensed so that it may be available for inspection.

Conditions of possession.

9. No person shall be in possession of or attempt to obtain possession of a drug unless-,—

(a) he is licensed to import or export the drug; or

(b) he ii licensed or otherwise authorized to manufacture or supply the drug; or

(c) he is otherwise licensed by the Director of Medical Services or authorized by this Part or by an authority granted by the Director of Medical Services to be in possession of the drug; or

(d) he proves that the drug was supplied for his use by a medical practitioner or a veterinary surgeon or on and in accordance with a prescription:

Provided that this provision shall not apply in the case of a drug supplied to a person for his use by a medical practitioner or in accordance with a prescription if that person was at the time of the supply in course of receiving treatment from another medical practitioner in respect of addiction to any of the drugs or otherwise, and of being supplied with any of the drugs by or on a prescription given by that last-mentioned practitioner, and did not disclose that fact to the first mentioned practitioner before the drug was supplied to him.

Marking of packages or bottles.

10. (1) No person shall supply a drug unless the package or bottle containing it is plainly marked with the nature and amount of the drug contained therein.

(2) No person shall supply a preparation, admixture, extract or other article containing a drug unless the package or bottle is plainly marked—

(a) in the case of a powder, solution or ointment, with the total amount thereof in the package or bottle and the percentage of the drug in the powder, solution or ointment;

(b) in the case of tablets or other articles, with the amount of the drug in each article and the- number of articles in the package or bottle.

(3) This rule shall not apply to a preparation dispensed by a medical practitioner or on the proscription of a medical practitioner.

Registers to be kept my persons supplying.

11. (1) A person who is authorized to manufacture, supply, purchase, procure or otherwise obtain, possess, administer or dispense drugs shall comply with the following provisions—

(a) be shall enter or cause to be entered in a register kept for the sole purpose all supplies of drugs purchased or otherwise obtained by him and all dealings in drugs effected by him (including sales or supplies to persons outside Kenya) in the form and containing the particulars prescribed in the First Schedule;

(b) he shall make the entry with respect to drugs purchased or otherwise obtained by him on the day on which the drug is received, and with respect to a sale or supply by him of the drug on the day on which the transaction is effected; or, where that is not reasonably practicable, on the day after the day on which the drug is received or the transaction is effected;

(c) where he carries on business at more than one set of premises, he shall keep a separate register or registers in respect of each set of premises;

(d) he shall keep the register or registers in some part of the premises to which it relates, so that it or they shall at all times be available for inspection in accordance with the

provisions of the Act;

(e) he shall not cancel obliterate or alter an entry in the register or make therein an entry which is untrue in any particular but any mistake in an entry may be corrected by a marginal

note or footnote giving the correct particulars and dated:

and -

(f) he shall furnish to the Director of Medical Services, or to a person authorized by an order of the Director of Medical Services for the purpose, such particulars as the Director of Medical Services or such person may require in regard to purchases by him of drugs, stocks held by him of drugs and transactions effected by him in drugs.

(2 (Deleted by L.N. 151/1968.)

(3) With the approval of the Director of Medical Services, separate registers may be kept for separate departments of a business.

Alternatives to keeping of register.

12. (1) A medical practitioner who records in a daybook particulars of drugs administered, dispensed or supplied by him or by another person under his direct supervision or in his presence to a patient, together with the name and address of the patient and the date of the administration, dispensation or supply, may, in lieu of keeping the register required by rule 11, enter separately for each drug, in a separate book to be kept for the purpose, a proper reference to each entry in the day book which relates to the supply of a drug.

(2) A person lawfully keeping open shop for the retailing of poisons may, in lieu of keeping the register required by this Part, enter in a separate book to be kept for the purpose a proper reference to each entry in the Sale of Poisons Book kept by him relating to supply of drugs.

Meaning of “proper reference”.

13. In rule 12, “a proper reference” means a reference which is entered in the separate book under the same date as that on which the entry in the day book or in the Sale of Poisons Book was made and is otherwise such as to enable that entry to be easily identified.

Inspection of registers.

14. All such books shall at all times be available for inspection in accordance with the provisions of the Act.

Seller of poisons may manufacture, etc., in certain cases.

Cap 244.

15. (1) A person lawfully keeping open shop for the retailing of poisons in accordance with the Pharmacy and Poisons Act may—

(a) manufacture at the shop in the ordinary course of his retail business any preparation, admixture or extract of drugs;

(b) carry on at the shop the business of retailing, dispensing or compounding drugs, but subject to the provisions of this Part.

(2) Every drug in the actual custody of a person authorized by virtue of this rule shall be kept in a locked receptacle which can be opened only by him or by some assistant of his being an authorized seller of poisons within the meaning of section 24 of the Pharmacy and Poisons Act.

(3) In the event of any such person being convicted of an offence under this Part or of an offence under any law relating to the customs, the Director of Medical Services may by notice in the Gazette withdraw the authorization in paragraph (1) if, in the opinion of the Director of Medical Services, that person cannot properly be allowed to carry on the business of manufacturing, selling or distributing, as the case may be, drugs.

Medical practitioner, etc., may possess and supply drugs in certain cases.

16. A medical practitioner, dentist or veterinary surgeon, or a person employed or engaged in dispensing medicines at. a public hospital or other public institution, or a person in charge of a laboratory for the purposes of research or instruction attached to a public hospital, or other institution approved by the Director of Medical Services for the purpose, may, so far as is necessary for the practice of his profession or employment in that capacity, be in possession of and supply drugs; but a dentist shall not supply otherwise than by the personal administration thereof by him to persons receiving treatment from him.

Withdrawal of authority.

17. (1) if a person authorized by this Part or by an authority granted by the Director of Medical Services to manufacture, supply or possess drugs is convicted of an offence under the Act or these Rules or under any law relating to the customs as applied by the Act or these Rules, the Director of Medical Services may, if he is of the opinion that that person ought not to be allowed to manufacture, supply or possess drugs, by notice in the Gazette, withdraw the authority of that person: but nothing in this rule shall prejudice any power otherwise vested in the Director of Medical Services of withdrawing an authority given by him.

(2) Where the person whose authority is withdrawn under paragraph (1) is a medical practitioner, dentist or veterinary surgeon, the Director of Medical Services may, by notice in the Gazette, direct that that person shall not give prescriptions for the purposes of these Rules.

(3) If the Director of Medical Services has reason to suspect that a medical practitioner or dentist is supplying or prescribing drugs to or for himself or another person otherwise than is properly required for the purpose of medical or dental treatment of himself or that other person the Director of Medical Services may refer the matter to the Board constituted under section 4 of the Medical Practitioners and Dentists Act (Cap. 253), and, if the Board so recommends, the Director of Medical Services may, by notice in the Gazette, withdraw the authority of the medical practitioner or dentist to supply, procure or possess drugs and give the direction with respect to him as may be given under paragraph (2).

Delivery to messengers.

18. (1) No person shall deliver drugs to a person not licensed or otherwise authorized to be in possession of drugs who purports to be sent by or on behalf of a person so 1icensed or authorized, unless the first-mentioned person produces an authority in writing, signed by the person so licensed or authorized, to receive the drug on his behalf, and unless the person supplying the drug is satisfied that the authority is genuine.

(2) A person to whom a drug is lawfully delivered in the circumstances, mentioned in paragraph (1) shall be deemed to be a person authorized to be in possession thereof, but for such period only as in the circumstances of the case is reasonably sufficient to enable the delivery to the recipient to be effected.

(3) This rule shall not apply to medicines dispensed in accordance with the provisions of this Part.

When drugs in possession of person.

19. Drugs in the order or disposition of a person shall be deemed to be in his possession.

Power to exempt hospitals

20. The Minister may exempt from the operation of this Part any hospital or other public institution, subject to the observance of such conditions as he may prescribe.

Exemption of certain preparations.

21. (1) This Part shall not apply to drugs when denatured in a manner approved by the Minister nor to preparations named in the Third Schedule.

(2) The Minister may, by order, add or remove a preparation to or from the Third Schedule.

Preservation of records.

22. Prescriptions, records, registers or other documents required to be retained or kept in pursuance of this Part or an order made thereunder shall be preserved for not less than two years from the date of the prescription or document or the last entry in the record or register, as the case may be.

PART III—CONTROL OF EXTERNAL TRADE

Interpretation of Part.

23. In this Part, except where the contest otherwise requires—

“conveyance” includes a ship, motor vehicle, aircraft, train and any other means of transport by which goods may be imported-or exported;

“diversion certificate” means a certificate issued by the competent authority of a country through which a dangerous drug passes in transit, authorizing the diversion of the drug to a country other than that specified as the country of ultimate destination in the export authorization, and containing all the particulars required to be included in an export authorization, together with the name of the country from which the consignment was originally exported; -

“export”, in relation to Kenya, means export otherwise than in transit;

“export authorization” means an authorization issued by a competent authority in a country from which a dangerous drug is exported, containing full particulars of the drug and the quantity authorized to be exported, together with the names and addresses of the exporter and the person to whom it is to be sent, and stating the country to which, and the period within which, it is to be exported;

“import”, in relation to Kenya, means export otherwise than in transit;

“import authorization” means a licence, issued by a competent authority, authorizing the importation of a specific quantity of a dangerous drug and containing full particulars of the drug, together with the name and address of the person authorized to import the drug and the name and address of the person from whom the drug is to be obtained, and specifying the period within which he importation must be effected; -

“import certificate” means a certificate substantially in Form A in the Second Schedule, issued by a competent authority in a country into which it is intended to import dangerous drugs;

“in transit” means taken or sent from one country and imported (whether or not landed or transhipped in Kenya) for the sole purpose of being carried to another country by either the same or another conveyance.

Export of dangerous drugs.

24. (1) Upon the production of an import certificate issued, by the competent authority in any country, the Director of Medical Services may issue an export authorization in Form B in the Second Schedule, in respect of a drug referred to in the import certificate, to a person who is named as the exporter in the certificate and is, under the Act, otherwise lawfully entitled to export the drug.

(2) The export authorization shall be prepared in triplicate, two copies of which shall be issued to the exporter, who shall send one copy with the drug to which it when the drug is exported; and the Director of Medical Services shall send the third copy direct to the appropriate authority of the country of ultimate destination.

(3) Where the intended exportation is to a country which is not a party to the Geneva Convention (No. 1), it shall not be necessary to produce an import certificate.

(4) In all cases it shall be in the absolute discretion of the Director of Medical Services to issue or refuse an export authorization.

(5) No dangerous drug shall be exported unless the consignor is in possession of a valid and subsisting export authorization relating to the drug granted under these Rules.

(6) At the time of exportation of a dangerous drug, the exporter shall produce to the Commissioner of Customs and Excise the dangerous drug, the expert authorization relating (hereto and such other evidence as the Commissioner of Customs and Excise may require to satisfy him that the drug is being lawfully exported to the place and person named in the authorization which refers t it.

(7) No person shall export or take any stops preparatory to exporting a dangerous drug except in pursuance of and in accordance with these Rules.

Import of dangerous drugs.

25. (1) An import authorization in Form C in the Second Schedule permitting the importation of a dangerous drug specified therein may be granted by the Director of Medical Services subject to such conditions as he deems lit to a person who may lawfully import the drug.

(2) Every import authorization shall be issued in duplicate, of which one copy shall be forwarded by the intending importer to the person from whom, the drug is to be obtained.

(3) No dangerous drug shall be imported unless the person to whom the drug is consigned is in possession of a valid and subsisting import authorization granted in pursuance of this rule.

(4) Every dangerous drug imported from a country which is party to the Geneva Convention (No. 1) shall be accompanied by a valid and subsisting export authorization or diversion certificate.

(5) No person shall import or take any steps preparatory, to importing a dangerous drug except in pursuance of and in accordance with these Rules.

Dangerous drugs in transit.

26. (1) No person shall bring a dangerous drug into Kenya in Dangerous transit unless—

(a) the drug is in course of transit from a country from which it may lawfully be exported, to another country into which the drug may lawfully be imported; and

(b) except where the drug comes from a country not a party to the Geneva Convention (No.1), it is accompanied by a valid and subsisting export authorization or diversion certificate, as the case may be.

(2) Where a dangerous drug in transit is accompanied by an export authorization or diversion certificate and a customs officer has reasonable grounds for believing that the authorization or certificate is false, or that it has been obtained by fraud or wilful misrepresentation of a material particular, the customs officer may seize and detain the drug to which that authorization or certificate relates; but upon being satisfied that the authorization or certificate is valid or has not been obtained by fraud or misrepresentation, the customs officer shall release the drug.

(3) Where the dangerous drug in transit is not accompanied by an export authorization or diversion certificate by reason of the fact that the drug comes from a country not a party to the Geneva Convention (No. 1), and a customs officer, administrative officer or police officer has reasonable grounds for believing that the drug is being conveyed in an unlawful manner or for an unlawful purpose or is in course of transit for the purpose of being imported into another country in contravention of the laws of that country, the customs officer, administrative officer or police officer may seize and detain the drug.

(4) Where a dangerous drug brought into Kenya in transit is landed, or transhipped in Kenya it shall remain under the control of the Commissioner of Customs and Excise, and shall be moved only under and in accordance with a removal licence granted under rule 27.

(5) Nothing in this rule shall apply to a dangerous drug in transit by post or in transit by air if the aircraft passes over Kenya without landing, or to such quantities of dangerous drugs as may, bona fide, reasonably form part of the medical stores of a ship or aircraft. -

Removal licence.

21. (1) No person shall—

(a) remove a dangerous drug from the conveyance by which it is brought into Kenya in transit; or

(b) in any way move any such drug in Kenya at any time after removal from the conveyance except under and in accordance with a licence in Form U in the Second Schedule (in these Rules referred to as a removal licence) issued by the Commissioner of Customs and Excise; and in all cases it shall be in the absolute discretion of the Commissioner of Customs and Excise to issue or refuse a removal licence.

(2) No removal liceuce for the transfer of a dangerous drug to a conveyance for removal out of Kenya shall be issued unless and until a valid and subsisting export authorization or diversion certificate relating to it is produced to the Commissioner of Customs and Excise, but where the drug has come from a country not a party to the Geneva Convention (No. 1) this paragraph shall not apply.

(3) This rule shall not apply to dangerous drugs in transit by post.

Drugs not to be tampered with.

28. No person shall cause a dangerous drug in transit to be subjected to a process which would alter its nature, or wilfully open or break a package containing a dangerous drug in transit except upon the instructions of the Commissioner of Customs and Excise and in such manner as he may direct

29. (1) No person shall, except under the authority of a diversion certificate in Form B in the Second Schedule, cause or procure a dangerous drug brought into Kenya in transit to be diverted to a destination other than that to which it was originally consigned; and in the case of a drug in transit accompanied by an export authorization or a diversion certificate issued by a competent authority of some other country, the country to which the drug was originally consigned shall be deemed to be the country slated in the export authorization or diversion certificate to be the country of destination.

(2) The Director of Medical Services may issue a diversion certificate of a dangerous drug in transit upon production to him of a valid and subsisting import certificate issued by a competent authority in the country to which it is proposed to divert the drug, or if that

country is not a party to the Geneva Convention (No. 1) upon such evidence as may satisfy him that the drug is to be sent in a lawful manner and for a proper purpose.

(3) A diversion certificate shall be issued in duplicate; one copy thereof shall accompany the drug when it is exported, and another copy shall be dispatched by the Director of Medical Services direct to the proper authority in the country to which the consignment has been diverted.

(4) Upon the issue of a diversion certificate, the export authorization or diversion certificate (if any) accompanying the drug on its arrival in Kenya shall be detained by the customs officer and returned to the authority issuing the authorization or diversion certificate, together with a notification of the name of the country to which the drug has been diverted.

Periodical returns.

30. (1) A person being in possession of or producing or manufacturing a drug in Kenya shall furnish to the Director of Medical Services, at such intervals as he may specify, such particulars and returns as he may require in regard thereto.

(2) A person importing a drug shall furnish in the month of January in every year to the Director of Medical Services an estimate of the amount of any such drugs to be imported by him during that year.

Drugs to be imported or exported only through appointed ports. Cap. 472

31. The importation or exportation of any drug to which these Rules apply shall be permissible only through the ports appointed imported or under section 9 of the Customs and Excise Act.

|Name of substance |Date on which supply |Name of person, body |Address of person, |Amount obtained |Form in which |

|purchased or |received |or firm from whom |body or firm from | |obtained |

|otherwise obtained | |obtained |whom obtained | | |

| | | | | | |

| | | | | | |

| | | | | | |

(b) REGISTER OF DRUGS TO WHICH PART V OF THE DANGEROUS DRUGS ACT APPLIES – SOLD OR SUPPLIED

|Name of |Date on which |Name of |Address of |Authority of |Amount sold or|Form in which |When sale is on a |

|substance sold |transaction was |person, body |person, body |person, body or |supplied |sold or |prescription, |

|or supplied |effected |or firm to |or firm to |firm to be in | |supplied |specify the |

| | |whom sold or |whom sold or |possession of the| | |ingredients or the |

| | |supplied |supplied |substance | | |prescription |

| | | | | | | | |

| | | | | | | | |

| | | | | | | | |

SECOND SCHEDULE

Form A (r.23)

Import Certificate issued by Serial No. ………………

the Government of Kenya. File No. ………………….

INTERNATIONAL OPIUM CONVENTIONS

THE DANGEROUS DRUGS ACT

IMPORT AUTHORIZATION

I, being the person charged with the administration of the law relating to dangerous drugs to which the International Opium Conventions apply, hereby certify that I have approved the importation by*

*Here insert

name address

and business of

importer.

†Here insert

exact description

and amount of

drugs to be

imported.

‡Here insert

name and

address of firm

in exporting

country from

which the drug is

to be obtained.

subject to the conditions that—

(i) the consignment shall be imported before the and

(ii) the consignment shall be imported by

and that I am satisfied that the consignment proposed to be imported

is required—

(1) for legitimate purposes;

§ Strike out

words not

applicable -

(2) § solely for medicinal or scientific purposes.

………………………………………………………………………

Signature and stamp of the authority which

has issued the import authorization

Date ……………………………

Form B (r. 24)

File No ……………………….

Applicant's

Reference No ………………..

Serial No……………………….

THE DANGEROUS DRUGS ACT

EXPORT AUTHORIZATION

In pursuance of the Dangerous Drugs Act, the Director of Medical Services hereby authorizes

(hereinafter called the exporter)

*Strike out

words not

applicable

to export from

(1) *the port of by S.S.

(2) *Kenya by parcel post in

parcels from the Post Office

to in

in virtue of Import Certificate No. dated

issued by

the following drugs, namely:—

This authorization is issued subject to the following conditions:-

1. This authorization is not a licence to obtain or be in possession of the drugs named herein.

2. This authorization is available only for drugs of the exact quantity, kind and form specified above.

3. This authorization does not relieve the exporter from compliance with ant customs regulations in force for the time being relating to the exportation of goods from Kenya nor from any provision of the Kenya Posts and Telecommunications Corporation Act, or of any regulations made thereunder, nor from any rules or regulations respecting the transmission of articles by post which may for the time being be in force, whether within Kenya or elsewhere.

4. If the drugs are authorized, to be exported by ship the duplicate copy, which is attached, shall accompany the consignment to the place of destination, and for this purpose the exporter shall cause it to be delivered to the master of the vessel by which the consignment is dispatched. (See footnote (3).)

5. If the drugs are authorized to be exported by post the attached duplicate copy shall be placed inside the outer wrapper of the parcel containing the drugs. If the drugs are contained in more than one parcel, the duplicate copy shall be placed inside the outer wrapper of one of them; the parcels shall be consecutively numbered on the outer wrapper, and on each parcel there shall be legibly stated the number of the parcel in which the duplicate copy is to be found. (See footnote (2).)

6. The exporter, if so required by the Commissioner of Customs and Excise, shall produce to him, within such time as he may allow, proof to his satisfaction that the drugs were duly delivered at the destination named in this authorization, and in the event of noncompliance with this condition the authorization shall be deemed void and of no effect.

7. The exporter shall furnish to the Director of Medical Services such returns of the goods exported by him in pursuance of this authorization as may from time to time be required.

8. This authorization is valid only for the exporter named above, and may be revoked at any time by the Director of Medical Services. It shall be produced for inspection when required by any duly authorized person.

9. This authorization, unless sooner revoked, shall continue in force for three calendar months from the date hereof. It must be produced, at the time of export, to an officer of—

*the Customs and Excise Department,

*the Kenya Posts and Telecommunications Corporation,

who will retain it.

If not used, it shall be surrendered to the Director of Medical Services within seven days of the date of its expiry

*Strike out

words not

Applicable.

Date

……………………………………………………………

Signature and stamp of Director

of Medical Services

Notes.—(1) it any alteration is desired in this authorization, it must be returned with a request for amendment and a statement of the reasons therefor. No unauthorized alteration is permissible.

(2) In the case of drugs exported by post, failure to comply with this condition may lead to delay or confiscation of the parcels in the country of destination.

(3) In the case of drugs exported by skip, this document is required in pursuance of the International Opium Convention, 1925, Article 15, to be produced to the competent authorities of any country through which the consignment passes, whether it is transhipped or not. Failure to comply with the condition may lead to delay or confiscation of the consignment.

Form C

(r. 25)

INTERNATIONAL OPIUM CONVENTION

THE DANGEROUS DRUGS ACT

IMPORT AUTHORIZATION AND CERTIFICATE OF OFFICIAL APPROVAL OF IMPORT

I, being the person charged with the administration of the law relating to the dangerous drugs to which the International Opium Conventions apply, hereby certify that I have authorized*

* Here insert

name and full

postal address

of importer.

(hereinafter called the importer) to import the drugs specified in the Schedule hereto, which I am satisfied are required:—

† Strike out

words not

applicable.

(1) † for legitimate purposes [in the case of raw opium or the coca leaf]

(2) † solely for medicinal or scientific purposes [in the case of Indian hemp or drugs to which Chapter III of the International Opium Convention, 1925, applies]

†Here insert

name and

full postal

address of

exporter.

from‡

This authorization is issued subject to the following conditions:—

1. The drugs shall be imported before [date].

2. This authorization is not a licence to be in possession of or to supply the drug imported.

3. This authorization does not relieve the importer from compliance with any customs regulations in force for the time being relating to the importation of goods into or transhipment of goods in Kenya or any postal regulations for the time being in force in Kenya.

4. This authorization is valid only for the importer, and may be revoked at any time and in that event shall be immediately surrendered. It shall be produced for inspection when required by any duly authorized person.

5. This authorization unless sooner revoked shall be surrendered to the Customs Officer at the time of importation, or, if the importation is not effected before the date specified in condition No. 1, shall immediately after that date be surrendered to the Director of Medical Services.

6. The copy of the export authorization, if any, which accompanies the consignment shall be forwarded to the Director of Medical Services immediately the importation of the consignment has been effected.

Date

………………………………………………………….

Signature and stamp of the

issuing authorial

SCHEDULE specifying the drugs and quantities thereof to be imported.

One copy of this authorization is to be retained by the importer, and is not to leave his possession until it is surrendered to the Director of Medical Services, or to the Customs Officer, who will complete the certificate on the back and return it to the Director of Medical Services.

The duplicate copy is solely for production to the government of the country from which the drug is proposed to be obtained.

ENDORSEMENT BY CUSTOMS OFFICER AT THE TIME OF IMPORTATION

I hereby certify that the person named overleaf has today imported the consignment thereon specified ‡ ex‼

under Customs Entry No. dated

¶by registered parcel post or insured box post (Parcel No.

dated

§See note below.

‼Insert name of

ship.

¶Strike out all

words

inapplicable

Port Stamp

…………………………………………………….

Signature of Customs Officer

Rank ………………………………………………..

Port ………………………………………………….

Date ………………………………

§ If the whole of the drugs for which this authorization has been granted is not imported, the Custom Officer should suitably amend the certificate above, and insert below the actua amount or items-imported.

|Amount |Description of items |

| | |

| | |

| | |

| | |

This authorization, when completed, must be returned by the Customs Officer to the Director of Medical Services.

Form D

THE DANGEROUS DRUGS ACT

(r. 27)

LICENCE FOR THE REMOVAL OF DANGEROUS DRUGS TN TRANSIT ……………………………… is hereby authorized to move the dangerous drugs described hereunder from ………………

To …………………………………

Nature and quantity of dangerous drugs ………………………..

Particulars of export authorization (or diversion certificate) if any, relating thereto ……….

Name of ship on which the drugs were brought into Kenya ………………………………………..

…………………………………………………………………………………………………………………………………………..

Date of arrival ………………………………………………………………………………………………………………..

Number of packages ……………………………………………………………………………………………………..

Marks and numbers on packages ………………………………………………………………………………..

This licence is issued subject to the following conditions:—

1. This licence is valid only for the removal of the drugs specified above.

2. The removal of the drugs shall take place between .... a.m./p.m. and .... a.m./p.m. on the 19. ..

3. If the removal of the drugs does not take place within the hours and on the day specified, this licence must be returned to the Commissioner of Customs and Excise forthwith; and in any case shall be surrendered when the removal has taken place.

4. The drugs must not be moved unless an officer of the Customs and Excise Department is present

5. This licence does not authorise the person named above to be in possession of the drugs otherwise than for the purpose of removing them in accordance with this licence.

6. The packages containing the drugs are not to be opened or broken in the course of the removal.

7. This licence shall be produced at any time when required by a duly authorized person.

Date ………………………………. ……………………………………………

Signature and stamp of the

issuing authority

Form E (r. 29)

INTERNATIONAL OPIUM CONVENTIONS

THE DANGEROUS DRUGS ACT

DIVERSION CERTIFICATE

I, being the person charged with the administration of the law relating to the dangerous drugs to which the International Opium Conventions apply, hereby certify that I have authorized the diversion of the consignment of drugs, of which particulars are given below, to the destination stated below.

Description and quantities of drugs …………………………………………………………….

Name of vessel on which the consignment was brought to Kenya ………………………….

Number and date of export authorization and authority by whom issued ……………

Name and address of original consignee named in the export authorization …………..

Name and address of consignee to whom consignment is authorized to be diverted …………………………………

Number and date of import certificate (and authority by whom issued) by virtue of which this diversion is authorized ……………………………………..

Name of vessel on which the consignment is authorized to be carried from [name of port of Kenya] ………………………………………………………….

Period within which the consignment is to be carried from

Kenya ………………………………………………………………………………………….

This certificate is issued subject to the following conditions:—

1. The duplicate copy of this certificate shall accompany the consignment to the place of destination, and for this purpose shall be delivered to the master of the vessel by which the consignment is dispatched.

2. This certificate does not relieve any person who may be concerned with the carriage of the consignment of drugs specified above from compliance with any Customs regulations in force for the time being relating to the exportation of goods from Kenya.

3. This certificate is valid only for the consignment and for the period specified above, and may be revoked at any time.

4. If the consignment of drugs is not carried from Kenya within the period specified above this certificate shall be surrendered to the Director of Medical Services.

5. This certificate shall be produced at any time when required by a duly authorized -person.

…………………………………………………

Signature and stamp of the

issuing authority

Date ……………………………..

Notes.—(1) If any alteration is desired in this authorization, it must be returned with a request for amendment and a statement of the reasons therefor. No unauthorized , alteration is permissible.

(2) This document is required, in pursuance of the International Opium Convention, 1925, Article 15, to be produced to the competent authorities of any country through which the consignment passes, whether it is t, unshipped or not. Failure to comply with the condition may lead to delay or confiscation of the consignment.

THIRD SCHEDULE

(r. 21)

(a) MORPHINE PREPARATIONS

| | |In 1 bougie |

|1.Cereoli idioformi et |Idioform |0.320 gramme |

|morphinae |Morphine hydrochloride |0.016 gramme |

| |Oil of theobroma, sufficient to fill a | |

| |1-gramme mould | |

|2.Emplastrum opii |Elemi |20 grammes |

| |Terebinthina |30 ,, |

| |Cera flava |15 ,, |

| |Olibanum pulvis |18 ,, |

| |Benzoes pulvis |10 ,, |

| |Opii pulvis |5 ,, |

| |Balsami peruviani |2 ,, |

|3.Emplastrum opii |Extract of opium |25 ,, |

| |Refined elemi |25 ,, |

| |Diachylon plaster with gum |50 ,, |

|4.Emplastrum opii |Elemi |8 ,, |

| |Terebinthinoe communis |15 ,, |

| |Cerae flavae |5 ,, |

| |Olibani pulveratae |8 ,, |

| |Benzoes pulveratae |4 ,, |

| |Opii pulverati |2 ,, |

| |Balsami peruviani |1 grammes |

|5. Emplastrum opii |Opium, in very fine powder |10 grammes |

| |Resin plaster |90 ,, |

|6. Emplastrum opii (see formula |Mixed with other plasters contained the | |

|under 5) |British Pharmacopoeia or British | |

| |Pharmaceutical Codex. | |

|7. Linimentum opii |Tincture of opium |500 millilitres |

| |Liniment of soap |500 ,, |

|8.Linimentum opii (seeformula |Mixed with any other liniment of the | |

|under 7) |British Pharmacopoeia or of the British | |

| |Pharmaceutical Codex. | |

|9. Linimetum opii ammoniatum |Ammoniated liniment of camphor |30 |

| |Tincture of opium |30 |

| |Liniment of belladonna |5 |

| |Strong solution of ammonia |5 |

| |Liniment of soap to |100 |

|10. Linimentum opii ammoniatum |Mixed with any other British Pharmacopoeia| |

|(seeformula under 9) |or British Pharmaceutical Codex liniment. | |

|11. Caustic "Nerve Pastes" |Preparations containing, in addition to | |

| |morphine salts, or morphine and cocaine | |

| |salts, and made up with the requisite | |

| |proportion of creosote or phenol to | |

| |produce the consistency of a paste. | |

|12. Diarrhoea pills |Camphor |0.0648 gramme |

| |Lead acetate |0.013 ,, |

| |Bismuth subnitrate |0.162 ,, |

| |Tannic acid |0.068 ,, |

| |Opium powder |0.026 ,, |

|13. Pilulae digitalis et Opii |Digitalis leaves, in powder |0.31 gramme |

|compositae |Opium in powder |0.19 ,, |

| |Ipecacuanha root, in powder |0.13 ,, |

| |Quinine sulphate |0.78 ,, |

| |Syrup of glucose, a sufficient quantity to| |

| |make 12 pills. | |

|14. Pilulae hydrargyri cum Opio |Mercury pill |3.89 grammes |

| |Opium, in powder |0.19 gramme |

| |To make 12 pills. | |

|15. Pilulae hydrargyri cum Creta |Mercury, with chalk |0.78 gramme |

|et Opii |Compound powder of |0.78 gramme |

| |ipecacuanha * | |

| |Milk, sugar, a sufficient quantity | |

| |Syrup of glucose, a sufficient quantity. | |

| |To make 12 pills | |

|16. Pilulae ipecacuanha cum |Compound powder of ipecacuanha* |30 grammes |

|Scilla |Squill, in powder |10 ,, |

| |Ammoniacum, in powder |10 ,, |

| |Syrup of glucose, a sufficient quantity. | |

|17. Pilulae hydrargyri bichlorati|Bichloride of mercury triturated |10 centigrammes |

|cum Opii extracto |Extract of opium |20 ,, |

| |Extract of couch-grass |20 ,, |

| |Liquorice root in powder, quantity |20 ,, |

| |sufficient for 10 pills. | |

|18. Pilulae hydrargyri iodati cum|Hydrargyrum iodatum freshly prepared |50 ,, |

|Opii pulvere |Opium powder |20 ,, |

| |Powdered liquorice |30 ,, |

| |White honey, quantity sufficient for ten | |

| |pills. | |

|19. Pilula plumbi cum Opio |Lead acetate, in powder |80 grammes |

| |Opium, in powder |12 ,, |

| |Syrup of glucose (or a sufficient |8 ,, |

| |quantity). | |

|20. Pilulae Terebinthinae |Opium |0.5 gramme |

|compositae |Chinini sulfas |2 gramme |

| |Styrax liquidus |2 ,, |

| |Terebinthina laricina |8 ,, |

| |Magnesii subcarbonas, a sufficient | |

| |quantity to make 100 pills. | |

|21. Pulvis ipecacuanhae |Ipecacuanha root, in powder Opium in |10 ,, |

|compositus Syn.: Pulvis |powder |10 ,, |

|ipecacuanhae |Potassium sulpahate in powder |80 ,, |

|et Opii (Dovers powder) | | |

|22. Mixtures of Dovers powder |With mercury and chalk, aspirin, | |

|(seeformula under 21) |phenacetin, quinine and its salts, and | |

| |sodium bicarbonate. | |

|23. Pulvis kino compositus |Kino, in powder |75 grammes |

| |Opium, in powder |5 ,, |

| |Cinnamon bark, in powder |20 ,, |

|24.Suppositoria plumbi composita.|Lead acetate, in powder |2.4 ,, |

|Syn.: Sup- positoria plumbi cum |Opium, in powder |0.8 gramme |

|Opio |Oil of theobroma, a sufficient quantity |1 gramme |

| |for | |

| |12 suppositories, each weighing about | |

|25. Coryza Tablets No.2 |Powdered opium |0.0043 gramme |

| |Quinine sulph. |0.022 ,, |

| |Ammon. chlor |0.022 ,, |

| |Camhpor |0.022 ,, |

| |Ext. Belladonna leaves |0.0043 ,, |

| |Ext. aconite root |0.0043 ,, |

|26. Diarrhoea Tablets No.2 |Powdered opium |0.016 ,, |

| |Camphor |0.016 ,, |

| |Powdered ipecacuanha |0.008 ,, |

| |Lead acetate |0.011 ,, |

|27. Dysentry Tablets |Powdered opium |0.013 ,, |

| |Powdered ipecacuanha |0.0648 ,, |

| |Powdered calomel |0.0324 ,, |

| |Lead acetate |0.0324 ,, |

| |Bismuth betanaphthol | |

|28. Tabella hydrargyri cum Opio |Mercurous chloride powder |0.1944 ,, |

| |Antimony oxide powder |0.065 ,, |

| |Ipecacuanha-root powder |0.065 ,, |

| |Powdered opium |0.065 ,, |

| |Milk sugar |0.065 ,, |

| |Gelatine solution, a sufficient quantity |0.065 ,, |

| |to make 1 tablet. | |

|29.Tabella hydrargyri cum Opio |Sugar of lead |0.195 ,, |

| |Powdered opium |0.065 ,, |

| |Gelatine solution, a sufficient quantity | |

| |to make 1 tablet. | |

|30.Tabella hydrargyri cum Opio |Lead acetate, in powder |19.44 grammes |

| |Opium, in powdered |3.24 ,, |

| |Refined sugar, in powder |6.48 ,, |

| |Ethereal solution of theobroma |3.60 mils. |

| |Alcohol |0.90 mil |

|31.Unguentum gallae compositum |Galls in very fine powder |20 |

| |Extracts of opium |4 |

| |Distilled water |16 |

| |Wool fat |10 |

| |Soft parrafin, yellow |50 |

|32. Unguentum gallae compositum |Mixed with other ointments and plasters | |

|(seeformula under 31) |contained in the british Pharmacopoeai or | |

| |British Pharmaceutical Codex. | |

|33. Unguentum gallae cum |Gall ointment |92.5 grammes |

|Opio |Opium in powder |7.5 ,, |

|34.Unguentum gallae cum Opio |Mixed with other ointments and plasters | |

|(seeformula under 33) |contained in the british Pharmacopoeai or | |

| |British Pharmaceutical Codex. | |

|35.Yatren-105 |With 5 per cent opium admixture. | |

|(Iodoxyquinoline-sul- phonic | | |

|acid) | | |

| |(b) COCAINE PREPARATIONS | |

|1.Bernatzik's Injections |(a) Hydrargyrum bicyanatum |0.03 grammes |

| |Cocainum |0.02 ,, |

| |(b) Hydrargyrum succinatum |0.03 ,, |

| |Cocainum |0.01 ,, |

|2. Stila's Injections |(a) Hydrargyrum succinatum |0.03 ,, |

| |Cocainum muriaticum |0.01 ,, |

| |(b) Hydrargyrum succinatum |0.05 ,, |

| |Cocainum muriaticum |0.03 ,, |

|3.Natrium biboracicum compositum |In tablets, compressed tablets, lozenges, | |

|cum Co- caino |pastilles and the like, difficult to break| |

| |up, and containing not more than 0.2 per | |

| |cent of cocaine salts in conjunction with | |

| |not less than 20 per cent antipyrine, or | |

| |some similar analgesic, and not more than | |

| |40 per cent of flavouring matter. Maximum | |

| |weight of each tablet, etc., 1 gramme. | |

|4.Caustic "Nerve Pastes" |Preparations containing, in addition to | |

| |cocaine and morphine salts, at least 25 | |

| |per cent of arsenoius acid, and made up | |

| |with the requisite proportion of cresoate | |

| |or phenol to produce the consistency of a | |

| |paste. | |

|5. Cocaine and Atropine Tablets, |Atropinum sulphuricum |0.0003 gramme |

|with a content of not more than |Cocainum hydrochloricum |0.0003 ,, |

|0.0003 gramme of atropine salts |Mannite |0.003 ,, |

|to each tablet |Weight of one tablet |_____________ |

| |Cocaine content 8.3 per cent. | |

| | |0.0036 gramme |

| | | |

| |(c) HEROIN PREPARATIONS | |

|1. Elixir camphorae compositum |Camphor |4 grains |

| |Oil of anise |5 minims |

| |Benzoic acid |6 grains |

| |Diamorphine hydrochloride |4 |

| |Liquid extract of ipecacuanha |120 minims |

| |Tincture of squill |1½ fl. Ounces |

| |Simple syrup to 20fl. ounces | |

|2. Elixir diamorphinae et |Amomorphine hydrochloride |5 grains |

|Terpini, with Apomorphine |Diamorphine hydrochloride |4 grains |

| |Terpin hydrate |44 grains |

| |Alcohol |10 fl. Ounces |

| |Glycerine |5 “ |

| |Syrup of wild cherry to 20 fl. ounces | |

|3. Linctus diamorphinae, with |Liquid extract of ipecacuanha |120 minims |

|Ipecacuanha |Diamorphine hydrochloride |4 grains |

| |Tincture of hyoscyamus |1½ fl. Ounce |

| |Spirit of chloroform |1½ “ |

| |Syrup of balsam of tolu |3 “ |

| |Syrup of wild cherry |3 “ |

| |Glycerine to 20 fl. Ounces | |

|4. Linctus senegae compositus |Liquid extract of senega |1 fl. Ounce |

| |Liquid extract of squill |1 “ |

| |Tartarated antimony |8 grains |

| |Diamorphine hydrochloride |4 “ |

| |Glycerine |2. fl. Ounces |

| |Simple syrup to 20 fl. Ounces | |

|5. Linctus thymi compitus |Diamorphine hydrochloride |4 grains |

| |Apomorphine hydrochloride |5 “ |

| |Distilled water |1 fl ounce |

| |Liquid extract of thyme (I-I) |5 fl ounces |

| |Solution of tolu |1¼ “ |

| |Glycerine to 20 fl. Ounces | |

| |(d) DICODIDE PREPARTIONS | |

|1. Cardiazol-Dicodide Solution |Solutions containing not less than 10 per | |

| |cent of cardiazol and not more than 0.5 | |

| |per cent of dicodide salts | |

| |(e) EUCODAL PREPARATIONS | |

|1. Anti-Opium Tablets* |Eucodal |1 gramme |

| |Pulvis gentianae |35 grammes |

| |Pulvis ipecacuanhae |20 ,, |

| |Quinine sulphate |20 ,, |

| |Caffeine |5 ,, |

| |Sugar of milk | |

| |Mix up and make up 5-grain tablets. | |

|2. Tablets B.B Compound |Berberis vulgaris powder |0.0324 gramme |

| |Nux vomica |0.013 ,, |

| |Eucodal |0.0032 ,, |

| |Ipecacuanha |0.0648 ,, |

| |Rhubarb |0.013 ,, |

| |Pulvis cinnamoni comositus |0.0324 ,, |

| |Aromatic chalk |0.0032 ,, |

*In exempting this preparation from the operation of the Geneva Convention, the Health Committee expressed the wish it should not be offered to the public under the name of “anti-opium”.

Order under section 14 (4)

Cap. 129 (1948), Sub Leg., G.N. 253/1951, G.N. 1274/1951, G.N. 549/1953, L.N. 478/1958.

THE DANGEROUS DRUGS (APPLICATION) ORDER

1. This Order may be cited as the Dangerous Drugs (Application) Order.

2. Part V of the Act shall apply to the following drugs in the same manner as it applies to the drugs mentioned in section 14 (1) of the Act –

Dihydrodesoxymorphine (commonly known as desomorphine), its salts and any preparation, admixture, extract or other substance containing any proportion of dihydrodesoxymorphine.

Pethidine (1 methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester), its salts and any preparation, admixture, extract or other substance containing any proportion of pethidine.

Alphaprodine (a-4-Propionoxy-4-phenyl-l : 3-dimethyl-4-piperidine), its salts and any preparation, admixture, extract or other substance containing any proportion of betaprodine.

Amidone (6-Dimethylamino-4 : 4-diphenylheptan-3-one); its salts and any preparation, admixture, extract or other substance containing any proportion of amidone.

Betaprodine (B-4-Propionoxy-4-phenyl-l : 3-dimethyl-4-piperidine), its salts and any preparation, admixture, extract or other substance containing any proportion of betaprodine.

Demerol (l-methyl-4-phenyl-piperidine-4-carboxylic acid ethylester), its salts, and any preparation, admixture, extract or other substance containing any proportion of demerol.

Hydroxypethidine (Ethyl 4-m-hydroxyphenyl-l-methylpiperidine-4-carboxylate), its salts and any preparation, admixture, extract or other substance containing any proportion of hydroxypethidine.

Isoamidone (6-Dimethylamino-4 : 4-diphenyl-5-methylhexan-3-one). its salts and any preparation, admixture, extract or other substance containing any proportion of isoamidone.

Ketobemidone (4-Propionyl-4-m-hydroxyphenyl-l-methyI-piperidine), its salts and any preparation, admixture, extract or other substance containing any proportion of ketobemidone.

Methadol (6-Dimethylamino-4 : 4-diphenylheptan-3-ol), its salts and any preparation, admixture, extract or other substance containing any proportion of methadol.

Methadyl acetate (6-Dimethylamino-4 : 4-diphenyl-3-heptyl-acetate), its salts and any preparation, admixture, extract or other substance containing any proportion of methadyl acetate.

Metopon (Methyldihydromorphinone) : its salts and any preparation, admixture, extract or other substance containing any proportion of methyldihydromorphinone.

Phenadoxone (6-Morpholino-4 : 4-diphenylheptan-3-one), its salts and any preparation, admixture, extract or other substance containing any proportion of phenadoxone.

Dihydrocodeincj its salts and any preparation, admixture, extract or other substance containing any proportion of dihydrocodeine.

Acetyldihydrocodeine, its salts and any preparation, admixture, extract or other substance containing any proportion of acetyldihydro-'

codeine.

4-Propionoxy-4-phenyl-l-methyl-3-ethylpiperidine, its salts and any preparation, admixture, extract or other substance containing any proportion of 4-propionoxy-4-phenyl-l-methyl-3-ethylpiperidine.

3-Hydroxy-N-methylmorphinan. its salts and a".y preparation,

admixture, extract or other substance containing any proportion of

3-hydroxy-N-methylmorphinan.

3-methoxy-N-methylmorphinan (that is to say, dextromethorphan, levomethorphan and racemethorphan), its salts and any preparation, admixture, extract or other substance containing any proportion of 3-methoxy-N-methylmorphinan.

Alphameprodine, its salts and any preparation, admixture, extract or other substance containing any proportion of alphameprodine.

Alphaprodine, its salts and any preparation, admixture, extract or other substance containing any proportion of alphaprodine.

Betameprodine, its salts and any preparation, admixture, extract or other substance containing any proportion of betameprodine.

Diethylthiambutene, its salts and any preparation, admixture, extract or other substance containing any proportion of diethylthiambutene.

1 : 3-Dimethyl-4-phenyl-4-propionyloxyhexamethyleneimine, its salts and any preparation, admixture, extract or other substance containing any proportion of 1 : 3-dimethyl-4-phenyl-4-propionyloxy hexamethyleneimine.

Dimethylthiambutene, its salts and any preparation, admixture, extract or other substance containing any proportion of dimethylthiambutene.

Dioxaphetyl butyrate (4-morpholino-2:2-diphenyl ethyl butyrate), its salts and any preparation, admixture, extract or other substance containing any proportion of dioxaphetyl butyrate (4-morpholino 2 : 2-diphenyl ethyl butyrate).

Dipipanone, its salts and any preparation, admixture, extract or other substance containing any proportion of dipipanone.

Ethylmethylthiambutene, its salts and any preparation, admixture, extract or other substance containing any proportion of ethylmethylthiambutene.

Levorphanol, its salts and any preparation, admixture, extract or other substance containing any proportion of levorphanol.

Methyldesomorphine (6-methyl-^6-desoxymorphine), its salts and any preparation, admixture, extract or other substance containing any proportion of methyldesomorphine (6-methyl-^6-desoxymophine).

1-Methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester, its salts and any preparation, admixture, extract or other substance containing any proportion of l-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester.

Normethadone, its salts and any preparation, admixture, extract or other substance containing any proportion of normethadone

Phenomorphan (3-hydroxy-N-phenethylmorphinan), its salts and any preparation, admixture, extract or other substance containing any proportion of phenomorphan (3-hydroxy-N-phenethylmorphinan).

Propoxyphene (4-dimethylamino-l : 2-diphenyl-3-methyl-2-propionyloxybutane). its salts and any preparation, admixture, extract or other substance containing any proportion of propoxyphene (4-dimethylamino-l : 2-diphcnyl-3-methyl-2-propionyloxybutane).

Racemorphan, its salts and any preparation, admixture, extract or other substance containing any proportion of racemorphan.

Declaration under section 14 (5)

It has been declared that findings with respect to the following preparations have, in pursuance of Article .8 of the Geneva Convention (No. 1), been communicated to the parties to that Convention and Part V of the Act ceases to apply to those preparations -

(a) MORPHINE PREPARATIONS

| | |In 1 bougie |

|1. Cereoli iodoformi et morphinae|Iodoform |0.320 grame |

| |Morphine hydrochloride |0.016 gramme |

| |Oil of theobroma, sufficient to fill a | |

| |1-gramme mould | |

|2. Emplastrum opii |Elemi |20 grammes |

| |Terebinthina |30 |

| |Cera flava |15 |

| |Olibanum pulvis |18 |

| |Benzoes pulvis |10 |

| |Opii pulvis |5 |

| |Balsanum peruvianum |2 |

|3. Emplastrum opii |Extract of opium |25 |

| |Refined elemi |25 |

| |Diachylon plaster with gum |50 |

|4. Emplastrum opii |Elemi |8 |

| |Terebinthinoe communis |15 |

| |Cerae flavae |5 |

| |Olibani pulveratae |8 |

| |Benzoes pulveratae |4 |

| |Opii pulverati |2 |

| |Balsami peruviani |1 gramme |

|5. Emplastrum opii |Opium, in very fine powder |10 grammes |

| |Resin plaster |90 |

|6. Empiastrum opii (see |Mixed with other plasters contained in | |

|formula under 5) |the British Pharmacop | |

|7. Linimentum opii |Tincture of opium |500 millilitres |

| |Liniment of soap |500 |

|8. Linimentum opii (see |Mixed with any other liniment of the | |

|formula under 7) |British Pharmacopoeia or of the British | |

| |Pharmaceutical Codex. | |

|9. Linimentum opii ammoniatum |Ammoniated liniment of camphor 30 | |

| |Tincture of opium .. 30 | |

| |Liniment of belladonna .. 5 | |

| |Strong solution of ammonia .. 5 | |

| |Liniment of soap to .. .. 100 | |

|10. Linimentum opii ammoniatum |Mixed with any other British | |

|(see formula under 9) |Pharmaco-poeia or British Pharmaceutical | |

| |Codex | |

| |liniment | |

|11. Caustic “Nerve Pastes” |Preparations containing, in addition to | |

| |morphine salts, or morphine and cocaine | |

| |salts, at least 25 per cent of arsenious | |

| |acid, and made up with the requisite | |

| |proportion of creosote or phenol to | |

| |produce the consistency of a paste. | |

|12. Diarrhoea pills |Camphor |0.0648 gramme |

| |Lead acetate |0.013 |

| |Bismuth subnitrate |0.162 |

| |Tannic acid |0.0648 |

| |Opium power |0.026 |

|13. Pilulae digitalis et Opii |Digitalis leaves, in powder |0.31 gramme |

|compositae |Opium, in power |0.19 |

| |Ipecacuanha root, in powder |0.13 |

| |Quinine sulphate |0.78 |

| |Syrum of glucose, a sufficient quantity to| |

| |make 12 pills | |

|14. Pilulae hydrargyri cum Opio |Mercury pill |3.89 grammes |

| |Opium, in powder |0.19 |

| |To make 12 pills. | |

|15. Pilulae hydragyri cum Creta |Compound powder of ipecacuanhas* |0.78 gramme |

|et Opii |Milk, sugar, a sufficient quandty |0.78 |

| |Syrup of glucose, a sufficient quantity. | |

| |To make 12 pills | |

|16. Pilulae ipecacuanha cum |Compound powder of ipecacuanhas* |30 grammes |

|Scilla |Squill, in powder |10 |

| |Ammoniacum, in powder |10 |

| |Syrup of glucose, a sufficient quantity. | |

|17. Pilulae hydrargyri bichlorati|Bichloride of Mercury triturated |10 centigrammes |

|cum Opii extracto |Extract of opium |20 |

| |Extract of couch-grass |20 |

| |Liquorice root in powder, quantity | |

| |sufficient for 10 pills | |

|18. Pilulae hydrargyri iodati cum|Hydrargyrum iodatum freshly prepared Opium|50 centigrammes |

|Opii pulvere |powder |20 |

| |Powdered liquorice |30 |

| |White honey, quantity sufficient for ten | |

| |pills | |

|19. Pilula plumbi cum Opio |Lead acetate, in powder |80 grammes |

| |Opium, in powder |12 |

| |Syrup of glucose (or a sufficient |8 |

| |quantity) | |

|20. Pilululae Terebinthinae |Opium |0.5 gramme |

|compositae |Chinini sulfas |2 grammes |

| |Styrax liquidus |2 |

| |Terebinthina laricina |8 |

| |Magnesii subcarbonas, a sufficient | |

| |quantity to make 100 pills | |

|21. Pulvis ipecacuanhae |Ipecacuanha root, in powder |10 grammes |

|compositus Syn: |Opium, in powder |10 |

|Pulvis ipecacuanhae et Opii |Potassium sulphate, in powder |80 |

|(Dover’s powder) | | |

|22. Mixtures of Dover’s powder |With mercury and chalk, aspirin, | |

|(see formula ndeir 21) |phenacetin, quinine and its salts, and | |

| |sodium bicarbonate | |

|23. Pubes lino compositus |Kino, in powder |75 grammes, |

| |Opium, in powder |5 „ |

| |Cinnamon bark, in powder . |20 |

|24. Suppositoria plumbi compoita,|Lead acetate, in powder |2.4 |

|Syn.: Suppositoria |Opium in powder |0.8 |

|Plumbi cum Opio |Oil of theobroma, a sufficient quantity | |

| |for 12 suppositories, each weighing about | |

| |1 gramme | |

|25. Coryza Tablets No. 2 |Powered opium |0.0043 gramme |

| |Quinine sulph |0.022 |

| |Ammon. Chlor |0.022 |

| |Camphor |0.022 |

| |Ext. Belladonna leaves |0.0043 |

| |Ext. aconite root |0.0043 |

|26. Diarrhoea Tablets No. 2 |Powdered opium .. |0416 |

| |Camphor .. |0-016 |

| |Powdered ipecacuanha |0.008 |

| |Lead acetate |0.01 |

|27. Dysentery Tablets |Powdered opium |0413 |

| |Powdered rpecacuanha |0-0648 |

| |Powdered calomel |04324 |

| |Lead acetate |04324 |

| |Bismuth betanaphthol |0.1944 |

| |Mercurous chloride powder |0.065 |

|28. Tabella hydrargyri cum Opio |Antimony oxide powder |0.065 |

| |Ipecacurinha-root powder |0.065 |

| |Powdered opium |0.065 |

| |Milk sugar |0.065 |

| |Gelatine solution, a sufficient quantity |20 „ |

| |to make 1 tablet. | |

|29. Tabella plumbi cum Opio |Sugar of lead |0.195 |

| |Powdered opium |0.065 |

| |Gelatine solution, a sufficient quantity | |

| |to make 1 tablet | |

|30. Tablettae plumbi cum Opio |Lead acetate, in fine powder |19.44 |

| |Opium, in powder |3.24 |

| |Refined sugar, in powder |6.48 |

| |Ethereal solution of theobroma |3.60 |

| |Alcohol |0.90 |

|31. Unguentum gallae compositum |Galls in very fine powder .. 20 | |

| |Extract of opium .. .. 4 | |

| |Distilled water .. 16 | |

| |Wool fat .. 10 | |

| |Soft paraffin, yellow | |

|32. Unguentum gallae compositum |Mixed with other ointments and plasters | |

|(see formula under 31) |contained in the British Pharmacopoeia or | |

| |British Pharmaceutical Codex | |

|33. Unguetum gallae cum Opio |Gall ointment |92.5 grammes |

| |Opium in powder |7.5 |

|34. Unguentum gallae cum Opio |Mixed with other ointments and plasters | |

|(see formula under 33) |contained in the British Pharmacopoeia or | |

| |British Pharmcopoeia or British | |

| |Pharmaceutical Codex | |

|35. Yatren-105 |With 5 per cent opium admixture | |

|(Iodooxyquinoline-sulphonic acid)| | |

| |(b) COCAINE PREPARATIONS | |

|1. Bernatzik’s Injections |(a) Hydrargyrum bicyanatum |0.03 gramme |

| |Cocain= .. |0.02 „ |

| |(b) Hydrprgyrum succinatum |0.03 „ |

| |Cocainum |0.01 |

| |(a) Hydrargyrum succinaturn |0.03 |

| |Cocainum muriaticum |0.01 |

| |(b) Hydrargyrutrt succinatum |0.05 |

| |Cocainum muriaticum |0.03 |

|3. Natrium biboracicum compositum|In tablets, compressed tablets, lozenges, pastilles and ihe like, |

|cum Coca-ino |difficult to break up, and containing not more than 0.2 per cent of |

| |cocaine salts in conjunction with not less than 20 per cent borax and not |

| |less than 20 per cent antipyrine, or some similar analgesic, and not more |

| |tham 40 per cent of flavouring matter. Maximuin weight of each tablet, |

| |etc., 1 gramme. |

|4. Caustic “Nerve Pastes” |Preparations containing, in addition to cocaine salts or cocaine and |

| |morphine salts, at least 25 per cent of arsenious acid, and made up with |

| |the requisite proportion of creosote or phenol to produce the consistency |

| |of a paste. |

|5. Cocaine and Atropine Tablets, |Atropinum sulphuric= .. |0.0003 gramme |

|with a content of not more than |Cocainum hydrochloricum Marmite 0.003 „ |0.0003 „ |

|0.0003 gramme of cocaine salts | |0.003 |

|and not less than 0.0003 gramme |Weight of one tablet .. | |

|of atropine salts to each tablet |Cocaine content 8.3 per cent. |0.0036 gramme |

| |(c) HEROIN PREPARATIONS | |

|1. Elixir camphorae compositum |Camphor |4 grains |

| |Oil of anise |5 minims |

| |Benzoic acid .. |6 grains |

| |Diamorphine hydrochloride |4 |

| |Liquid extract of ipecacuanha |120 minims |

| |Tincture of squill. |1½ fl. ounces |

| |Simple syrup to 20 fl. ounces. | |

|2. Elixir diamorphinae et |Apomorphine hydrochloride .. |5 grains |

|Terpini, with Apomorphine |Diamorphine hydrochloride |4 |

| |Terpin hydrate .. |44 |

| |Alcohol .. , |10 fl. Ounces |

| |Glycerine .. |5 |

| |Syrup of wild cherry to 20 fl. ounces. | |

|3. Linctus diamorphinae with |Liquid extract of ipecacuanha |120 minims |

|Ipecacuanha |Diamorphine hydrochloride |4 grains |

| |Tincture of hyoscyamus |1 ½ fl. Ounces |

| |Spirit of chloroform .. |1½ fl. Ounces |

| |Syrup of balsam of tolu |3 |

| |Syrup of wild cherry .. |3 |

| |Glycerine to 20 fl. ounces. | |

|4. Linctus senegae compositus |Liquid extract of senega |1 fl ounce |

| |Liquid extract of squill .. |1 ounce |

| |Tartarated antimony .. |8 grains |

| |Diamorphine hydrochloride |4 grains |

| |Glycerine .. . |2 fl ounces |

| |Simple syrup to 20 fl. ounces. | |

|5. Linctus thymi compositus |Diamorphine hydrochloride |4 grains |

| |Apomorphine hydrochloride |5 grains |

| |Distilled water .. |1 fl ounce |

| |Liquid extract of thyme (I-I) |5 fl. Ounces |

| |Solution of tolu |1¼ |

| |Glycerine to 20 fl. ounces. | |

| |(d) DICODIDE PREPARATIONS | |

|1. Cariazol-Dicodide Solutions |Solutions containing not less than 10 per cent of | |

| |cardiazol | |

| |and not more than 0.5 per cent of dicodide salts. | |

| |(e) EUCODAL PREPARATIONS | |

|1. Anti-Opium Tablets* |Eucodal |1 gramme |

| |Pulvis gentianae |35 grammes |

| |Pulvis ipecacuatthae |20 grammes |

| |Quinine rulphate |20 grammes |

| |Caffeine |5 grammes |

| |Sugar of milk |25 grammes |

| |Mix up and make up 5-grain tablets. | |

|2. Tablets B.B Compound |Berberis vulgaris powder |0.0324 gramme |

| |Nux vomica |0.013 |

| |Eucodal |0.0032 |

| |Ipecacuanha |0.0648 |

| |Rhubarb |0.013 |

| |Pulvis cinnamon compositus |0.0324 |

| |Aromatic chalk |0.0032 |

*In exempting this preparation from the operation of the Geneva Convention, the Health Committee expressed the wish that it should not be offered to the public under the name of "anti-opium”

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download